Usefulness of clinical parameters for screening the patients with overt/subclinical Cushings syndrome complicated with or without hyperaldosteronism in order to clarify pathogenesis of hypertension in those patients.

Usefulness of clinical parameters for screening the patients with overt/subclinical Cushings syndrome complicated with or without hyperaldosteronism in order to clarify pathogenesis of hypertension in those patients. - The pathogenesis of hypertension in the patients with subclinical Cushings syndrome.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000022161

Enrollment

Registered

2016-05-01

Start date

2016-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overt Cushings syndrome and Subclinical Cushings syndrome

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who have adrenal incidentaloma and are suspected to have hypercortisolism.

Exclusion criteria

Exclusion criteria: Patients who reject the areement.

Design outcomes

Primary

Measure	Time frame
The frequency of hypertensive complications, induced by hyperaldosteronism in patients with overt/subclinical Cushings syndrome.	—

Secondary

Measure	Time frame
Improvement of endocrine function and complications for these statuses after adrenalectomy.	—

Countries

Japan

Contacts

Public ContactKosuke Inoue

Yokohama Rosai Hospital Endocrinology & Diabetes Center

koinoue-tky@umin.ac.jp045-474-8111

Outcome results